Trial Profile
Open Label Pharmacokinetic Study of Granexin Gel in Patients With Diabetic Foot Ulcers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Jun 2022
Price :
$35
*
At a glance
- Drugs ACT 1 (Primary)
- Indications Diabetic foot ulcer
- Focus Pharmacokinetics
- Sponsors Xequel Bio
- 31 Jul 2018 Status changed from active, no longer recruiting to completed.
- 06 Feb 2018 Planned End Date changed from 1 Jan 2018 to 1 Apr 2018.
- 06 Feb 2018 Status changed from recruiting to active, no longer recruiting.